You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Busulfan

Showing 26 - 50 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

Recruiting
  • GATA2
  • +2 more
  • Allogeneic HSCT
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell

Recruiting
  • Severe Combined Immunodeficiency, X Linked
  • Gene Therapy
  • autologous CD34+ cell transduced with G2SCID vector
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
Has Results
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,

Recruiting
  • Immunodeficiency
  • Hematopoietic Stem Cell Transplantation
  • Post-Transplant Cyclophosphamide (PTCY)
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Busulfan
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

Recruiting
  • Primary CNS Lymphoma
  • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
  • Moscow, Russian Federation
    Nathional Medical Research Center for Hematology
Jun 16, 2022

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

    Active, not recruiting
    • HIV
    • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
    • Duarte, California
    • +4 more
    Mar 7, 2022

    Disease-free Survival Trial in Shanghai (MBF-RIC)

    Recruiting
    • Disease-free Survival
    • Shanghai, Shanghai, China
    • +1 more
    Jun 28, 2022

    Acute Lymphoblastic Leukemia Trial in Seoul (Busulfan)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Busulfan
    • Seoul, Daehangno, Jongno-gu, Korea, Republic of
      Seoul National University Hospital
    Jun 15, 2021

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • +3 more
    • Allogeneic Bone Marrow Transplantation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

    Active, not recruiting
    • Chronic Granulomatous Disease Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • +2 more
    • GSTA1 genotyping
    • Geneva, Switzerland
      Hôpitaux Universitaires de Genève
    Jul 30, 2021

    Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

    Completed
    Has Results
    • Myeloid Hematological Malignancies
    • Busulfan
    • +3 more
    • Houston, Texas
      Texas Children's Hospital
    May 13, 2022

    Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

    Suspended
    • Hematologic Neoplasms
    • donor lymphocyte infusion
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 30, 2022

    Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

    Not yet recruiting
    • Essential Thrombocythemia
    • (no location specified)
    Oct 6, 2023

    Acute Leukemia Trial in Shanghai (Busulfan)

    Recruiting
    • Acute Leukemia
    • Busulfan
    • Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 19, 2021

    Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

    Recruiting
    • Multiple Myeloma
    • Maywood, Illinois
      Loyola University Medical Center
    Apr 23, 2021

    Genetic Rare Disease Trial in Seoul (Busulfan)

    Recruiting
    • Genetic Rare Disease
    • Busulfan
    • Seoul, Daehangno, Jongno-gu, Korea, Republic of
      Seoul National University Hospital
    Mar 28, 2021